Bravera Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$723K Sell
2,845
-40
-1% -$9.32K 0.28% 48
2026
Q1
$705K Sell
2,885
-315
-10% -$73.4K 0.32% 48
2025
Q4
$662K Buy
+3,200
New +$633K 0.33% 43

Other funds holding JNJ

Bravera Wealth's JNJ Position: Q2 2026 in Review

Bravera Wealth reduced its Johnson & Johnson (JNJ) stake by 1.4% in Q2 2026, selling an estimated $9.32K and leaving 2,845 shares worth $723K. The position accounts for 0.28% of the portfolio, ranked #48.

Bravera Wealth first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 1,664 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bravera Wealth held 2,845 shares of Johnson & Johnson worth $723K as of Q2 2026.
  • Bravera Wealth sold 40 Johnson & Johnson shares in Q2 2026, an estimated $9.32K.
  • Johnson & Johnson made up 0.28% of Bravera Wealth's portfolio in Q2 2026, its #48 holding.
  • Bravera Wealth first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bravera Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.